BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26498869)

  • 21. Six-minute walk test closely correlates to "real-life" outdoor walking capacity and quality of life in patients with intermittent claudication.
    Nordanstig J; Broeren M; Hensäter M; Perlander A; Osterberg K; Jivegård L
    J Vasc Surg; 2014 Aug; 60(2):404-9. PubMed ID: 24690492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological response to the 6-minute walk test in chronic heart failure patients versus healthy control subjects.
    Deboeck G; Van Muylem A; Vachiéry JL; Naeije R
    Eur J Prev Cardiol; 2014 Aug; 21(8):997-1003. PubMed ID: 23513011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical observation of cardiopulmonary exercise test in patients with idiopathic pulmonary arterial hypertension].
    Luo Q; Liu ZH; Ma XP; Zhao ZH; Gu Q; Xiong CM; Ni XH; He JG; Zhao Q
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1683-6. PubMed ID: 24124671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
    Gomberg-Maitland M; Huo D; Benza RL; McLaughlin VV; Tapson VF; Barst RJ
    J Heart Lung Transplant; 2007 Jul; 26(7):732-8. PubMed ID: 17613405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-minute walking test to assess exercise tolerance and cardiorespiratory responses during training program in children with congenital heart disease.
    Moalla W; Gauthier R; Maingourd Y; Ahmaidi S
    Int J Sports Med; 2005 Nov; 26(9):756-62. PubMed ID: 16237621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The 6 minute walking test: a cost-effective alternative to spiro-ergometry in patients with chronic heart failure?].
    Haass M; Zugck C; Kübler W
    Z Kardiol; 2000 Feb; 89(2):72-80. PubMed ID: 10768274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional capacity and risk stratification by the Six-minute Walk Test in Chagas heart disease: comparison with Cardiopulmonary Exercise Testing.
    Costa HS; Lima MM; de Sousa GR; de Souza AC; Alencar MC; Nunes MC; Rocha MO
    Int J Cardiol; 2014 Dec; 177(2):661-3. PubMed ID: 25449475
    [No Abstract]   [Full Text] [Related]  

  • 28. Small, unrepaired ventricular septal defects reveal poor exercise capacity compared with healthy peers: A prospective, cohort study.
    Maagaard M; Heiberg J; Hjortdal VE
    Int J Cardiol; 2017 Jan; 227():631-634. PubMed ID: 27810297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficiency of the home cardiac rehabilitation program for adults with complex congenital heart disease.
    Bhasipol A; Sanjaroensuttikul N; Pornsuriyasak P; Yamwong S; Tangcharoen T
    Congenit Heart Dis; 2018 Nov; 13(6):952-958. PubMed ID: 30216680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The six-minute walk test cannot predict peak cardiopulmonary fitness in ambulatory adolescents and young adults with cerebral palsy.
    Slaman J; Dallmeijer A; Stam H; Russchen H; Roebroeck M; van den Berg-Emons R;
    Arch Phys Med Rehabil; 2013 Nov; 94(11):2227-33. PubMed ID: 23796684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Oemrawsingh RM; Baggen VJ; Kardys I; Cuypers JA; Witsenburg M; van Schaik RH; Roos-Hesselink JW; Boersma E
    Int J Cardiol; 2016 Jan; 202():246-51. PubMed ID: 26402453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VE/VCO2 slope and oxygen uptake efficiency slope in patients with coronary artery disease and intermediate peakVO2.
    Van de Veire NR; Van Laethem C; Philippé J; De Winter O; De Backer G; Vanderheyden M; De Sutter J
    Eur J Cardiovasc Prev Rehabil; 2006 Dec; 13(6):916-23. PubMed ID: 17143123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
    Wessler BS; Kramer DG; Kelly JL; Trikalinos TA; Kent DM; Konstam MA; Udelson JE
    Circ Heart Fail; 2011 Sep; 4(5):578-88. PubMed ID: 21705485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of abnormal heart rate recovery in patients with heart failure reduced and preserved ejection fraction.
    Cahalin LP; Arena R; Labate V; Bandera F; Guazzi M
    Eur J Prev Cardiol; 2014 Jul; 21(7):906-14. PubMed ID: 23335654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease.
    Ohuchi H; Tanabe Y; Kamiya C; Noritake K; Yasuda K; Miyazaki A; Ikeda T; Yamada O
    Circ J; 2013; 77(2):470-6. PubMed ID: 23059769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validity of the six-minute walk test in cancer patients.
    Schmidt K; Vogt L; Thiel C; Jäger E; Banzer W
    Int J Sports Med; 2013 Jul; 34(7):631-6. PubMed ID: 23444095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.
    Guazzi M; Labate V; Cahalin LP; Arena R
    Eur J Prev Cardiol; 2014 Jul; 21(7):847-54. PubMed ID: 23382540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart rate recovery after the 6 min walk test rather than distance ambulated is a powerful prognostic indicator in heart failure with reduced and preserved ejection fraction: a comparison with cardiopulmonary exercise testing.
    Cahalin LP; Arena R; Labate V; Bandera F; Lavie CJ; Guazzi M
    Eur J Heart Fail; 2013 May; 15(5):519-27. PubMed ID: 23397578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.
    Diller GP; Dimopoulos K; Okonko D; Li W; Babu-Narayan SV; Broberg CS; Johansson B; Bouzas B; Mullen MJ; Poole-Wilson PA; Francis DP; Gatzoulis MA
    Circulation; 2005 Aug; 112(6):828-35. PubMed ID: 16061735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.